Actuate Therapeutics Inc
USD1.88
-0.11 (-5.53%)
CEO
Daniel Schmitt
IPO Date
2024-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.98
Prev. Close
$1.99
Day Low
$1.85
Day High
$1.98
52W Low
$1.58
52W High
$10.90
Market Cap
$0.04B
Volume
0.08M
| 15,000 |
| $2.42 |
| 22 May 2026 | Sawhney Roger | director | A-Award | Acquired | 15,000 | $2.42 |
| 22 May 2026 | RONNEBERG AMY L | director | A-Award | Acquired | 15,000 | $2.42 |
| 22 May 2026 | Keyes Jason A | director | A-Award | Acquired | 15,000 | $2.42 |
| 22 May 2026 | Huber Martin H. Jr. | director | A-Award | Acquired | 15,000 | $2.42 |
| 22 May 2026 | Fletcher Aaron G.L. | director, 10 percent owner: | A-Award | Acquired | 15,000 | $2.42 |
| 6 May 2026 | Huber Martin H. Jr. | director | Disposed | 30,000 | $3.00 |
| 1 Apr 2026 | SCHMITT DANIEL M | director, officer: President, CEO and Director | A-Award | Acquired | 237,000 | $2.49 |
| 1 Apr 2026 | Mazar Andrew Paul | Chief Operating Officer | A-Award | Acquired | 105,000 | $2.49 |